next-generation antibody-drug conjugates in her2 breast cancer
Published 3 years ago • 90 plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
2:10
targeting low her2 expression with antibody-drug conjugates
-
1:23
antibody-drug conjugates for the treatment of breast cancer
-
2:06
antibody-drug conjugates for her2-low disease: 2023 ku breast cancer year in review
-
0:49
optimizing patient selection for antibody drug conjugates in breast cancer
-
2:21
adcs for the treatment of her2-low breast cancer
-
1:38
dr. hart on antibody-drug conjugates in her2 breast cancer
-
1:11
development of antibody-drug conjugate therapies in breast cancer
-
6:51
adcs for her2 and her2-low breast cancer
-
3:36
her2 breast cancer: evolution of antibody-drug conjugates
-
25:46
antibody drug conjugates present and future applications in breast cancer
-
3:58
antibody drug conjugates in lung cancer
-
1:02
combination therapies incorporating adcs in breast cancer
-
3:01
resistance to adcs in breast cancer and novel combination strategies
-
2:03
dr. marks on investigational antibody-drug conjugates in her2 breast cancer
-
0:46
what does the future hold for adcs in breast cancer?
-
11:57
antibody-drug conjugates used in breast cancers | oncology 2022
-
10:21
novel antibody-drug conjugates (adcs) technologies for management of mbc
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
0:57
dr. cobleigh on antibody-drug conjugates in development in her2 breast cancer